SG/PUT/AMGEN/250/0.1/21.03.25 Share Price

DE000SU6QYM1

Market Closed - Boerse Frankfurt Warrants 19:13:08 05/07/2024 BST
0.73 ^EUR	-3.95%

Current month	+8.57%
1 month	-20.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart AMGEN INC.

Latest news about AMGEN INC.

Alvotech Says Study on Proposed Biosimilar to Prolia, Xgeva Meets Primary Endpoints	07-02	MT
Amgen Inc.(NasdaqGS:AMGN) added to Russell 1000 Dynamic Index	06-30	CI
Argus Raises Amgen's Price Target to $340 From $300	06-27	MT
Amgen CEO Bob Bradway’s Advice to Amgen’s Summer Interns: Don’t Hold Back	06-27	PU

More news

Quotes 5-day view

Date	Price	Change
05/07/24	0.73	-3.95%
04/07/24	0.76	+1.33%
03/07/24	0.75	+1.35%
02/07/24	0.74	+1.37%
01/07/24	0.73	+4.29%

Real-time Boerse Frankfurt Warrants

Last update July 05, 2024 at 07:13 pm

More quotes

Static data

Product type	Warrants
Buy / Sell	PUT
Underlying	AMGEN INC.
Issuer	Société Générale
WKN	SU6QYM
ISIN	DE000SU6QYM1
Date issued	08/01/2024
Strike	250 $
Maturity	21/03/2025 (259 Days)
Parity	10 : 1
Emission price	1.31 €
Emission volume	N/A
Settlement	règlement en espèces
Currency	EUR

Technical Indicators

Highest since issue	2.12 €
Lowest since issue	0.6 €
Delta	-0.16x
Omega	6.138
Premium	22.11x
Gearing	38.77x
Moneyness	0.8047
Difference Strike	-60.55 $
Difference Strike %	-24.22%
Spread	0.02 €
Spread %	2.67%
Theoretical value	0.7400
Implied Volatility	32.26 %
Total Loss Probability	76.69 %
Intrinsic value	0.000000
Present value	0.7400
Break even	241.99 €
Theta	-0.02x
Vega	0.06x
Rho	-0.03x

Company Profile

Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other (5.8%): primarily royalties. The United States account for 70.3% of net sales.

Sector

More about the company